SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

Clinical trial NCT01362790 · COMPLETED

Trial details

NCT number: NCT01362790
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mesothelioma Adenocarcinoma of Lung Pancreatic Neoplasms

Start date: 2011-05-11
Primary completion: 2016-08-03
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.